Diabetes Technology and Therapeutics Impact Factor, Quartile, Indexing, Ranking

Diabetes Technology and Therapeutics Impact Factor, Indexing, Ranking

Diabetes Technology and Therapeutics (DTr) is a scholarly journal dedicated to publishing research in the field of Medicine, and Published by Mary Ann Liebert. The Print-ISSN of Diabetes Technology and Therapeutics is 1520-9156 and its abbreviation is Dialogues Hum Geogr.

The latest Impact Factor of the Diabetes Technology and Therapeutics for 2024-2025 is 5.4.

The Publicaiton fees (APC) is $3,600 USD.


Diabetes Technology and Therapeutics Aim and Scope

Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.

Diabetes Technology & Therapeutics coverage includes:

  • Detection and prevention of long-term micro- and macrovascular complications
  • Breakthrough technologies and new therapeutic drug classes
  • Behavioral aspects and approaches to diabetes care
  • The latest advancement and applications of new and emerging technologies, including:
    • Alternate insulin delivery methods
    • Continuous glucose monitoring
    • Artificial pancreas
    • Computerized case management/telemedicine
    • New insulins with ultra-rapid onset of action
    • Detection and prevention of hypoglycemia

Diabetes Technology and Therapeutics Details


Journal title Diabetes Technology and Therapeutics (DTr)
Abbreviation Dialogues Hum Geogr
Print ISSN 1520-9156
Online ISSN 1557-8593
Publisher Name Mary Ann Liebert
Editor-in-chief Satish K. Garg
Subject Category Medicine
Access type Hybrid
Status 🟢 Active

Diabetes Technology and Therapeutics Metrics and Rankings

In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.

Below are the metrics and rankings for the journal Diabetes Technology and Therapeutics

Impact Factor 5.4
SJR 2.374
SNIP 1.908
Ranking 686
CiteScore 11.6
H-Index 97
Quartile Q1
Diabetes Technology and Therapeutics Impact Factor List

Diabetes Technology and Therapeutics Abstracting and Indexing

Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars

Abstracting and Indexing

Diabetes Technology and Therapeutics Submission

If you would like to submit a manuscript or visit the journal's website, please click on the link below.

Journal Submission 🔗 Journal Website

F T L W E